ArticleFrontiers in microbiology2012
Engineering microbial chemical factories to produce renewable "biomonomers".
Article in Frontiers in microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- A Review of Natural Polysaccharides: Sources, Characteristics, Properties, Food, and Pharmaceutical Applications.International journal of molecular sciences · 2024Review
- Engineering synthetic microbial consortium for cadaverine biosynthesis from glycerol.Biotechnology letters · 2022Article
- Closing the Gap between Bio-Based and Petroleum-Based Plastic through Bioengineering.Microorganisms · 2022Review
- Considering Strain Variation and Non-Type Strains for Yeast Metabolic Engineering Applications.Life (Basel, Switzerland) · 2022Review
- Genomics Characterization of an EngineeredFrontiers in bioengineering and biotechnology · 2021Article
- Metabolic engineering of Escherichia coli for polyamides monomer δ-valerolactam production from feedstock lysine.Applied microbiology and biotechnology · 2020Article
- Mechanistic insights into the dual activities of the single active site of l-lysine oxidase/monooxygenase fromThe Journal of biological chemistry · 2020Article
- Beyond Intracellular Accumulation of Polyhydroxyalkanoates: Chiral Hydroxyalkanoic Acids and Polymer Secretion.Frontiers in bioengineering and biotechnology · 2020Review
- Synthetic biology for fibres, adhesives and active camouflage materials in protection and aerospace.MRS communications · 2019Article
- Enhanced production of styrene by engineered Escherichia coli and in situ product recovery (ISPR) with an organic solvent.Microbial cell factories · 2019Article
- Twenty-first-century chemical odyssey: fuels versus commodities and cell factories versus chemical plants.Microbial biotechnology · 2019Review
- An Overview of Biorefinery Derived Platform Chemicals from a Cellulose and Hemicellulose Biorefinery.Clean technologies and environmental policy · 2018Article
- Synthesis of Low Melting Temperature Aliphatic-Aromatic Copolyamides Derived from Novel Bio-Based Semi Aromatic Monomer.Polymers · 2018Article
- Increasing the Resistance of Living Cells against Oxidative Stress by Nonnatural Surfactants as Membrane Guards.ACS applied materials & interfaces · 2018Article
- Synthetic biology strategies for improving microbial synthesis of "green" biopolymers.The Journal of biological chemistry · 2018Review
- Expanding beyond canonical metabolism: Interfacing alternative elements, synthetic biology, and metabolic engineering.Synthetic and systems biotechnology · 2018Review
- Current advance in bioconversion of methanol to chemicals.Biotechnology for biofuels · 2018Review
- Artificial de novo biosynthesis of hydroxystyrene derivatives in a tyrosine overproducing Escherichia coli strain.Microbial cell factories · 2015Article
- Review
- Methanol-based cadaverine production by genetically engineered Bacillus methanolicus strains.Microbial biotechnology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By applying metabolic engineering tools and strategies to engineer synthetic enzyme pathways, the number and diversity of commodity and specialty chemicals that can be derived directly from renewable feedstocks is rapidly and continually expanding. This of course includes a number of monomer building-block chemicals that can be used to produce replacements to many conventional plastic materials. This review aims to highlight numerous recent and important advancements in the microbial production of these so-called "biomonomers." Relative to naturally-occurring renewable bioplastics, biomonomers offer several important advantages, including improved control over the final polymer structure and purity, the ability to synthesize non-natural copolymers, and allowing products to be excreted from cells which ultimately streamlines downstream recovery and purification. To highlight these features, a handful of biomonomers have been selected as illustrative examples of recent works, including polyamide monomers, styrenic vinyls, hydroxyacids, and diols. Where appropriate, examples of their industrial penetration to date and end-product uses are also highlighted. Novel biomonomers such as these are ultimately paving the way toward new classes of renewable bioplastics that possess a broader diversity of properties than ever before possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.